Erector Spinae Plane Block in Minimal Invasive Cardiac Surgery
Overview
Studying the effect of erector spinae plane block in patients undergoing minimal invasive cardiac surgery.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Single (Outcomes Assessor)
- Study Primary Completion Date: November 30, 2020
Interventions
- Procedure: ESP Block
- 20 ml of lacal anaesthetics will be placed below the erector spinae muscle under ultrasound guide
- Drug: general anesthetic
- patient receive general anaesthetic only
Arms, Groups and Cohorts
- Active Comparator: ESP block group
- patients receive ESP Bock with local anaesthetics
- Placebo Comparator: control group
- general anaestesia
Clinical Trial Outcome Measures
Primary Measures
- VAS
- Time Frame: 48 hours
- PAIN SCORES OF PATIENTS
Participating in This Clinical Trial
Inclusion Criteria
- elective valve replacement Exclusion Criteria:
- chroic renal failure – chronic liver failure
Gender Eligibility: All
Minimum Age: 20 Years
Maximum Age: 50 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Assiut University
- Provider of Information About this Clinical Study
- Principal Investigator: Rasha Hamed, lecturer of anaesthesia and pain management – Assiut University
- Overall Contact(s)
- rasha hamed, lecturer, 01000440773, rashaahmed11@yahoo.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.